[Chemotherapy of hepatocellular carcinoma--with special reference to one-shot intra-arterial infusion of a high dose of adriamycin]. 1982

H Hirose, and M Aoyama, and K Oshima, and K Udo, and S Kobayashi, and N Adachi, and T Nonaka, and T Yamada

Twenty-two cases of non-operable hepatocellular carcinoma (HCC) were treated with three types of chemotherapy mainly with Adriamycin (ADM). In the group (A), one shot intraarterial infusion of 100 mg ADM into the hepatic artery (9 cases), group (B), one shot intraarterial infusion of 30 mg ADM (3 cases), and group (C), 20-60 mg of systemic administration of ADM (10 cases) were examined. The therapeutic effects and side effects were studied comparatively among these three groups. In terms of tumor regression, RR was 4 cases (44.4%), and MR was 4 (44.4%) in group (A), and PR was 1 (10%) in group (C). The average survival time was 8.3 months (5 cases are still alive) in group (A), 5.7 months in group (B), and 4.2 months in group (C), respectively As side effects, alopecia was found 100% in (A), 33% in (B); leukocytopenia was found 100% in (A), 33% in (B); but no serious complication due to leukocytopenia was observed in any of them. One shot of 100 mg of ADM intraarterial infusion therapy seemed to be superior in therapeutic effects against HCC over other therapies.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005260 Female Females
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Hirose, and M Aoyama, and K Oshima, and K Udo, and S Kobayashi, and N Adachi, and T Nonaka, and T Yamada
August 1996, Gan to kagaku ryoho. Cancer & chemotherapy,
H Hirose, and M Aoyama, and K Oshima, and K Udo, and S Kobayashi, and N Adachi, and T Nonaka, and T Yamada
January 1987, Cancer chemotherapy and pharmacology,
H Hirose, and M Aoyama, and K Oshima, and K Udo, and S Kobayashi, and N Adachi, and T Nonaka, and T Yamada
May 1973, Journal of surgical oncology,
H Hirose, and M Aoyama, and K Oshima, and K Udo, and S Kobayashi, and N Adachi, and T Nonaka, and T Yamada
March 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
H Hirose, and M Aoyama, and K Oshima, and K Udo, and S Kobayashi, and N Adachi, and T Nonaka, and T Yamada
December 2007, Hepatology research : the official journal of the Japan Society of Hepatology,
H Hirose, and M Aoyama, and K Oshima, and K Udo, and S Kobayashi, and N Adachi, and T Nonaka, and T Yamada
February 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
H Hirose, and M Aoyama, and K Oshima, and K Udo, and S Kobayashi, and N Adachi, and T Nonaka, and T Yamada
April 2010, Seminars in oncology,
H Hirose, and M Aoyama, and K Oshima, and K Udo, and S Kobayashi, and N Adachi, and T Nonaka, and T Yamada
September 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
H Hirose, and M Aoyama, and K Oshima, and K Udo, and S Kobayashi, and N Adachi, and T Nonaka, and T Yamada
June 1986, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
H Hirose, and M Aoyama, and K Oshima, and K Udo, and S Kobayashi, and N Adachi, and T Nonaka, and T Yamada
August 1992, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!